BPH GLOBAL SECURES STRATEGIC INVESTMENT

Open PDF
Stock BPH Global Ltd (BP8.ASX)
Release Time 5 Feb 2026, 9:30 a.m.
Price Sensitive Yes
 BPH Global Secures $1M Strategic Investment
Key Points
  • $1M strategic placement at market price completed
  • Record and second highest monthly sales results
  • Proceeds to scale up Indonesian seaweed operations
Full Summary

BPH Global Ltd (ASX: BP8) has announced that it has received firm commitments to raise $1.0 million (before costs) through a strategic placement of fully paid ordinary shares. The placement strengthens the company's balance sheet at a key stage in the commercial development of its Indonesian seaweed platform and introduces new long-term shareholders aligned with the company's growth strategy. The placement includes one free attaching option for every two placement shares, exercisable at $0.004 with a three-year expiry, subject to shareholder approval. Proceeds from the placement will be used to scale up the company's Indonesian-based seaweed operations ($600,000), fund research and development initiatives ($200,000), provide working capital ($140,000) and cover the costs of the offer ($60,000). BPH Global operates from a fully commissioned warehouse facility in Makassar, Indonesia, and holds a valid Indonesian Government seaweed export licence, which reduces execution risk and enables the company to respond efficiently to increasing demand. The company will prioritise scaling its core trading operations through expanded procurement, increased export throughput and continued customer engagement, while also evaluating opportunities to enhance margins by increasing independently executed sales and selectively progressing downstream initiatives.

Outlook

With the placement completed, BPH Global is positioned to deploy capital in a measured manner, aligned with operational capacity and demonstrated market demand. The company will continue to sustain commercial growth while maintaining capital discipline as it progresses its broader strategy, including its longer-term biotechnology and functional nutrition initiatives.